Authors: Breuer, W Ermers, MJJ Pootrakul, P Abramov, A Hershko, C Cabantchik, ZI

Citation: W. Breuer et al., Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy, BLOOD, 97(3), 2001, pp. 792-798

Authors: Stark, B Sharon, R Rechavi, G Attias, D Ballin, A Cividalli, G Burstein, Y Sthoeger, D Abramov, A Zaizov, R

Citation: B. Stark et al., Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with Non-B-Cell acute lymphoblastic leukemia - The Israel National Study Report, CANCER, 88(1), 2000, pp. 205-216

Authors: Breuer, W Ronson, A Slotki, IN Abramov, A Hershko, C Cabantchik, ZI

Citation: W. Breuer et al., The assessment of serum nontransferrin-bound iron in chelation therapy andiron supplementation, BLOOD, 95(9), 2000, pp. 2975-2982

Authors: Eldor, A Durst, R Hy-Am, E Goldfarb, A Gillis, S Rachmilewitz, EA Abramov, A Maclouf, J Godefray, YC de Raucourt, E Guillin, MC

Citation: A. Eldor et al., A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood, BR J HAEM, 107(4), 1999, pp. 739-746